Substance / Medication

Frovatriptan

Overview

Active Ingredient
frovatriptan
RxNorm CUI
228783

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of frovatriptan as compared to other triptans in migraine with aura.
Evers Stefan, Savi Lidia, Omboni Stefano et al. · J Headache Pain · 2015
PMID: 25916333Meta-AnalysisFull text (PMC)
Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
Poolsup N, Leelasangaluk V, Jittangtrong J et al. · J Clin Pharm Ther · 2005
PMID: 16336284Meta-Analysis
Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
Coffee Andrea L, Sulak Patricia J, Hill Alexandria J et al. · J Womens Health (Larchmt) · 2014
PMID: 24450487RCT
Frovatriptan as preemptive treatment for fasting-induced migraine.
Latsko Meryl, Silberstein Stephen, Rosen Noah · Headache · 2011
PMID: 21269298RCT
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Silberstein Stephen D, Berner Todd, Tobin John et al. · Headache · 2009
PMID: 19751371RCT
Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
Seo Jong-Geun, Park Sung-Pa · Cephalalgia · 2016
PMID: 26170008Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Frovatriptan (substance)
SNOMED CT
411990007
UMLS CUI
C0754647
RxNorm CUI
228783

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.